LifeVantage (NASDAQ: LFVN) reported Q2 EPS of $0.01, $0.02 worse than the analyst estimate of $0.03. Revenue for the quarter came in at $48.2 million versus the consensus estimate of $56.45 million.

For earnings history and earnings-related data on LifeVantage (LFVN) click here.